Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $36.5700 (1.82%) ($36.5700 - $36.6700) on Tue. Mar. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 36 | Latest Price | $36.5700(1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -9.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(44%) IFRA(43%) XBI(43%) IWO(42%) IWM(40%) | Factors Impacting HALO price | HALO will decline at least -1.445% in a week (0% probabilities). VXX(-20%) VIXM(-11%) UUP(-9%) GLD(-9%) IGOV(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $12.48(-65.87%) | Resistance Level | $39.36 | 5 Day Moving Average | $34.7(5.39%) | 10 Day Moving Average | $35.2(3.89%) | 20 Day Moving Average | $39.36(-7.09%) | To recent high | -35.9% | To recent low | 11.4% | Market Cap | $4.998b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |